Redeye: ADDvise - Exceptional Quarter in Lab
Redeye retains its positive view of ADDvise following a strong Q2 report in line with the preliminary results. Lab had a strong quarter, especially margin-wise, mainly thanks to large deliveries of high-margin products. Following the solid report, ADDvise raised its 2023 proforma guidance, which we find reasonable. We raise our forecasts and Base Case somewhat.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/